title: Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
authors.affiliation: Department of Nephrology, Hospital Ramŏn y Cajal, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Pascual
authors.forename: M
authors.initials: M
authors.lastname: Crespo
authors.forename: M L
authors.initials: ML
authors.lastname: Mateos
authors.forename: R
authors.initials: R
authors.lastname: Marcén
authors.forename: L
authors.initials: L
authors.lastname: Orofino
authors.forename: F J
authors.initials: FJ
authors.lastname: Burgos
authors.forename: F
authors.initials: F
authors.lastname: Liaño
authors.forename: J
authors.initials: J
authors.lastname: Ortuño
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009369:Neoplasms / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use*; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011241:Prednisone